Search research articles
Contact Us
Filters
Showing results (31-40 of 53) with videos related to
Page
of 6
Sort By:
Carcinogenesis
|
August 1, 1995
Butadiene monoxide and deoxyguanosine alkylation products at the N7-position
I Neagu, P Koivisto, C Neagu, et al.
IARC Scientific Publications
|
January 1, 1994
Alkylation of purine bases with 3,4-epoxy-1-butene, a reactive metabolite of 1,3-butadiene
I Neagu, P Koivisto, C Neagu, et al.
American Heart Journal
|
February 1, 1987
Enhanced cholesterol elimination and synthesis related to low-density lipoprotein metabolism
T A Miettinen, Y A Kesäniemi, M Färkkilä, et al.
Progress in Clinical and Biological Research
|
January 1, 1991
Quantitative aspects of 32P-postlabeling
K Hemminki, K Szyfter, P Vodicka, et al.
IARC Scientific Publications
|
January 1, 1993
Estimating internal dose of 1,3-butadiene: preliminary data on use of modified purine bases as markers of exposure
K Peltonen, P Koivisto, I Neagu, et al.
Carcinogenesis
|
June 29, 1999
Butadiene diolepoxide- and diepoxybutane-derived DNA adducts at N7-guanine: a high occurrence of diolepoxide-derived adducts in mouse lung after 1,3-butadiene exposure
P Koivisto, I Kilpeläinen, I Rasanen, et al.
American Heart Journal
|
February 1, 1987
Regulation of low-density lipoprotein apolipoprotein B levels
Y A Kesäniemi, M Färkkilä, K Kervinen, et al.
The Journal of Urology
|
November 4, 2000
Androgen receptor gene amplification at primary progression predicts response to combined androgen blockade as second line therapy for advanced prostate cancer
C Palmberg, P Koivisto, L Kakkola, et al.
Gynecologic Oncology
|
September 23, 1997
Prognostic significance of p53 expression in ovarian granulosa cell tumors
S L Ala-Fossi, J Mäenpää, R Aine, et al.
The American Journal of Pathology
|
December 1, 1995
Analysis of genetic changes underlying local recurrence of prostate carcinoma during androgen deprivation therapy
P Koivisto, E Hyytinen, C Palmberg, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 53) with videos related to
Sort By:
Page
of 6
Carcinogenesis
|
August 1, 1995
Butadiene monoxide and deoxyguanosine alkylation products at the N7-position
I Neagu, P Koivisto, C Neagu, et al.
IARC Scientific Publications
|
January 1, 1994
Alkylation of purine bases with 3,4-epoxy-1-butene, a reactive metabolite of 1,3-butadiene
I Neagu, P Koivisto, C Neagu, et al.
American Heart Journal
|
February 1, 1987
Enhanced cholesterol elimination and synthesis related to low-density lipoprotein metabolism
T A Miettinen, Y A Kesäniemi, M Färkkilä, et al.
Progress in Clinical and Biological Research
|
January 1, 1991
Quantitative aspects of 32P-postlabeling
K Hemminki, K Szyfter, P Vodicka, et al.
IARC Scientific Publications
|
January 1, 1993
Estimating internal dose of 1,3-butadiene: preliminary data on use of modified purine bases as markers of exposure
K Peltonen, P Koivisto, I Neagu, et al.
Carcinogenesis
|
June 29, 1999
Butadiene diolepoxide- and diepoxybutane-derived DNA adducts at N7-guanine: a high occurrence of diolepoxide-derived adducts in mouse lung after 1,3-butadiene exposure
P Koivisto, I Kilpeläinen, I Rasanen, et al.
American Heart Journal
|
February 1, 1987
Regulation of low-density lipoprotein apolipoprotein B levels
Y A Kesäniemi, M Färkkilä, K Kervinen, et al.
The Journal of Urology
|
November 4, 2000
Androgen receptor gene amplification at primary progression predicts response to combined androgen blockade as second line therapy for advanced prostate cancer
C Palmberg, P Koivisto, L Kakkola, et al.
Gynecologic Oncology
|
September 23, 1997
Prognostic significance of p53 expression in ovarian granulosa cell tumors
S L Ala-Fossi, J Mäenpää, R Aine, et al.
The American Journal of Pathology
|
December 1, 1995
Analysis of genetic changes underlying local recurrence of prostate carcinoma during androgen deprivation therapy
P Koivisto, E Hyytinen, C Palmberg, et al.
Page
of 6